DK413987A - Substitueret phenylamidforbindelse - Google Patents

Substitueret phenylamidforbindelse

Info

Publication number
DK413987A
DK413987A DK413987A DK413987A DK413987A DK 413987 A DK413987 A DK 413987A DK 413987 A DK413987 A DK 413987A DK 413987 A DK413987 A DK 413987A DK 413987 A DK413987 A DK 413987A
Authority
DK
Denmark
Prior art keywords
phenylamide compound
substituted phenylamide
substituted
compound
phenylamide
Prior art date
Application number
DK413987A
Other languages
English (en)
Other versions
DK169404B1 (da
DK413987D0 (da
Inventor
Peter Thaddeus Gallagher
Terence Alan Hicks
Graham Walter Mullier
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of DK413987D0 publication Critical patent/DK413987D0/da
Publication of DK413987A publication Critical patent/DK413987A/da
Application granted granted Critical
Publication of DK169404B1 publication Critical patent/DK169404B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • C07D261/16Benzene-sulfonamido isoxazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK413987A 1986-08-08 1987-08-07 Substitueret phenylamidforbindelse, fremgangsmåde til fremstilling deraf, anvendelse deraf til brug som farmaceutisk middel og farmaceutisk præparat indeholdende forbindelsen DK169404B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8619432 1986-08-08
GB868619432A GB8619432D0 (en) 1986-08-08 1986-08-08 Pharmaceutical compounds

Publications (3)

Publication Number Publication Date
DK413987D0 DK413987D0 (da) 1987-08-07
DK413987A true DK413987A (da) 1988-02-09
DK169404B1 DK169404B1 (da) 1994-10-24

Family

ID=10602473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK413987A DK169404B1 (da) 1986-08-08 1987-08-07 Substitueret phenylamidforbindelse, fremgangsmåde til fremstilling deraf, anvendelse deraf til brug som farmaceutisk middel og farmaceutisk præparat indeholdende forbindelsen

Country Status (23)

Country Link
US (1) US4892963A (da)
EP (1) EP0257882B1 (da)
JP (1) JPS63239259A (da)
KR (2) KR880002815A (da)
CN (1) CN1015256B (da)
AR (2) AR244660A1 (da)
AT (1) ATE65494T1 (da)
AU (1) AU604737B2 (da)
CA (1) CA1317964C (da)
DE (1) DE3771611D1 (da)
DK (1) DK169404B1 (da)
EG (1) EG18269A (da)
ES (1) ES2031510T3 (da)
GB (1) GB8619432D0 (da)
GR (1) GR3002714T3 (da)
HU (1) HU197559B (da)
IL (1) IL83432A (da)
MX (1) MX174371B (da)
NZ (1) NZ221352A (da)
PH (1) PH22821A (da)
PT (1) PT85476B (da)
RU (1) RU1771472C (da)
ZA (1) ZA875813B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4975462A (en) * 1988-07-29 1990-12-04 Bristol-Myers Company Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
JPH04211048A (ja) * 1990-03-05 1992-08-03 Mitsubishi Kasei Corp チオカルバモイルアセトニトリル誘導体
DE59010701D1 (de) * 1990-05-18 1997-05-22 Hoechst Ag Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf 3-Cycloalkyl-prop-2- enamide derivatives
EP0538783B1 (de) * 1991-10-23 1995-09-27 Hoechst Aktiengesellschaft N-phenyl-2-cyano-3-hydroxycrotonsäureamidderivate und deren Verwendung als Arzneimittel mit immunmodulatorischer Eigenschaft
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
TW314467B (da) * 1993-03-31 1997-09-01 Hoechst Ag
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
GB9320299D0 (en) * 1993-10-01 1993-11-17 Roussel Lab Ltd Isoxazole derivatives
KR100365064B1 (ko) * 1994-10-17 2003-04-11 훽스트파마슈티칼스앤드케미칼스가부시키가이샤 I형알레르기성질환의예방및치료제
DE19702988A1 (de) * 1997-01-28 1998-07-30 Hoechst Ag Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
CN1411373A (zh) * 1999-12-16 2003-04-16 特瓦制药工业有限公司 制备来氟米特的新方法和新晶形的来氟米特
CA2400290A1 (en) * 2000-02-15 2001-08-23 Teva Pharmaceutical Industries Ltd. A method for synthesizing leflunomide
DE10311763A1 (de) * 2003-03-18 2004-10-07 Aventis Pharma Deutschland Gmbh Verfahren zur Herstellung von 2-Cyan-3-hydroxy-N-(phenyl)but-2-enamiden
US6894184B2 (en) 2003-03-18 2005-05-17 Aventis Pharma Deutschland Gmbh Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides
EP3071199A2 (en) 2013-11-22 2016-09-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DK545976A (da) * 1975-12-11 1977-06-12 Hoechst Ag Cyaneddikesyreanilidderivater fremgangsmade til deres fremstilling og midler der indeholder disse forbindelser
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten
DE2655009A1 (de) * 1976-12-04 1978-06-15 Hoechst Ag Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
ATE14724T1 (de) * 1979-06-11 1985-08-15 Ciba Geigy Ag Alphacarbamoyl-pyrrolpropionitrile, verfahren zu ihrer herstellung, sowie pharmazeutische praeparate die diese verbindungen enthalten.

Also Published As

Publication number Publication date
CN1015256B (zh) 1992-01-01
PT85476B (pt) 1990-06-29
GR3002714T3 (en) 1993-01-25
AR244660A1 (es) 1993-11-30
DK169404B1 (da) 1994-10-24
GB8619432D0 (en) 1986-09-17
ES2031510T3 (es) 1992-12-16
ZA875813B (en) 1989-04-26
AU604737B2 (en) 1991-01-03
MX7668A (es) 1993-08-01
ATE65494T1 (de) 1991-08-15
HU197559B (en) 1989-04-28
AU7668187A (en) 1988-02-11
HUT44523A (en) 1988-03-28
CA1317964C (en) 1993-05-18
KR880002815A (ko) 1988-05-11
PT85476A (en) 1987-09-01
EG18269A (en) 1992-12-30
JPS63239259A (ja) 1988-10-05
DE3771611D1 (de) 1991-08-29
US4892963A (en) 1990-01-09
AR247876A1 (es) 1995-04-28
NZ221352A (en) 1989-10-27
IL83432A0 (en) 1988-01-31
KR880002823A (ko) 1988-05-11
IL83432A (en) 1992-06-21
MX174371B (es) 1994-05-11
CN87105516A (zh) 1988-02-24
EP0257882B1 (en) 1991-07-24
RU1771472C (ru) 1992-10-23
EP0257882A1 (en) 1988-03-02
DK413987D0 (da) 1987-08-07
PH22821A (en) 1989-01-19

Similar Documents

Publication Publication Date Title
DE3751890D1 (de) Radionuklid-Antikörper-Verbindung
FI891478A7 (fi) Yhdiste
DK648687D0 (da) Quinolinforbindelse
DE3650706D1 (de) Substituierte Dicarboxypyridin-Verbindungen
DK85993A (da) 2-anilino-4-formyl-pyrimidinforbindelser
BA98296A (bs) Piperazinil-heterociklicna jedinjenja
FI893632A7 (fi) Yhdisteitä
DK164188C (da) Sammensat taetning
DK594687D0 (da) Pyrrolidinylthioforbindelser
DK413987A (da) Substitueret phenylamidforbindelse
DK492587A (da) Substituerede indolquinoxaliner
DK287688D0 (da) Heterocycliske forbindelser
PT84187A (pt) Novel compounds
DK227487A (da) Substituerede heterocycliske forbindelser
DK591887A (da) Antibiotiske forbindelser
PT86766A (pt) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds
DK290487A (da) Substituerede 3-amino-2-benzoylcyklohex-2-enoner
DK210487A (da) Substituerede benzimidazolderivater
DK435186D0 (da) Somatostatinforbindelse
IT1221792B (it) Composti metossimetilici
DK187686A (da) Benzisothiazol-s-oxidforbindelse
FI893924A7 (fi) Yhdisteitä
DK182487D0 (da) Octahydroquinolizinforbindelse
DE3789797D1 (de) Pyrimidinylphenyl-Ester-Verbindung.
DK375287D0 (da) Fungicid indeholdende substituerede thienylaminer

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed